Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Festus › NPI 1508859661
Hospital

Mercy Hospital Jefferson

Mercy Hospital Jefferson was paid $27.83M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99285, emergency room visit (most serious) — 21% of everything it billed.

33Billing provider infoMERCY HOSPITAL JEFFERSON
FESTUS, MO 63028
33aNPI1508859661assigned 08/24/2005
28Total paid$27.83M
24GClaims264,740
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Missouri

Rank by total paid#13 of 74
Median peer was paid$4.44M
This provider vs. median6.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201832,287$6.12M
201939,293$5.62M
202032,269$3.29M
202134,358$1.71M
202238,239$3.04M
202347,048$4.34M
2024incomplete41,246$3.72M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 21% 34,917 27,016 $5.94M
Y7506 17% 33,842 28,948 $4.63M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 24,099 18,942 $3.56M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 24,404 18,487 $2.92M
X4011 State-specific procedure code 10% 12,018 11,344 $2.86M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6.5% 36,818 33,263 $1.80M
80053 Comprehensive metabolic panel 5.4% 32,522 30,080 $1.51M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.8% 5,228 5,026 $512K
81001 1.6% 7,443 7,105 $444K
59025 Fetal non-stress test 1.3% 3,470 2,248 $364K
X4006 <1% 377 334 $248K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,862 2,692 $240K
108 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,478 $235K
71045 Radiologic examination, chest; single view <1% 4,091 $227K
X4003 <1% 1,686 $202K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,752 $157K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,330 $153K
97597 <1% 1,990 $146K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 738 $129K
84484 <1% 3,583 $112K
83690 <1% 1,336 $108K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 317 $104K
71046 Radiologic examination, chest; 2 views <1% 410 $85K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 378 $84K
96375 Therapeutic injection; each additional sequential IV push <1% 2,662 $83K
85610 <1% 1,090 $81K
84443 Thyroid stimulating hormone (TSH) <1% 2,864 $71K
87086 Culture, bacterial; quantitative colony count, urine <1% 382 $60K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 557 $51K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 727 $49K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 123 $43K
85730 <1% 303 $39K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 440 $37K
87081 <1% 503 $35K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 215 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 124 $29K
83880 <1% 688 $29K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 94 $26K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 942 $22K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 263 $20K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 245 $20K
81003 <1% 587 $17K
86140 <1% 282 $16K
85652 <1% 237 $15K
87631 <1% 46 $14K
36591 <1% 227 $14K
70450 Computed tomography, head or brain; without contrast material <1% 147 $14K
82077 <1% 995 $14K
84703 <1% 228 $12K
80048 Basic metabolic panel (calcium, ionized) <1% 148 $12K
81025 <1% 113 $12K
80076 <1% 174 $10K
87807 <1% 26 $10K
82565 <1% 147 $10K
85027 <1% 41 $9K
86235 <1% 62 $9K
93017 <1% 61 $9K
G0378 Hospital observation service, per hour <1% 26 $8K
83516 <1% 77 $8K
0240U <1% 66 $8K
82728 <1% 302 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 77 $6K
83615 <1% 329 $6K
96361 Intravenous infusion, hydration; each additional hour <1% 13 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 47 $6K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 26 $5K
84466 <1% 195 $5K
86200 <1% 38 $4K
86225 <1% 40 $4K
87634 <1% 12 $4K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 39 $4K
83540 <1% 195 $4K
86431 <1% 37 $4K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 31 $4K
36415 Collection of venous blood by venipuncture <1% 698 $4K
96367 <1% 95 $3K
99213 Doctor's office visit, returning patient (routine) <1% 105 $3K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 16 $3K
82746 <1% 121 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 185 $3K
Y7507 <1% 52 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 25 $2K
82607 <1% 94 $2K
95816 <1% 12 $2K
83735 <1% 608 $2K
82550 <1% 12 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 26 $976.25
99214 Doctor's office visit, returning patient (more involved) <1% 13 $948.26
87653 <1% 13 $858.88
86160 <1% 12 $843.47
74018 <1% 12 $737.02
80061 Lipid panel <1% 55 $694.62
86039 <1% 12 $667.47
73120 <1% 12 $639.68
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 12 $637.50
83036 Hemoglobin; glycosylated (A1C) <1% 120 $556.10
86038 <1% 12 $495.93
77336 <1% 21 $403.42
84702 <1% 41 $363.07
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 15 $337.96
J3490 Unclassified drugs <1% 1,798 $335.70
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 46 $189.73
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 27 $168.42
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 27 $168.42
83605 <1% 27 $167.46
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 15 $140.35
84165 <1% 13 $63.27
87088 <1% 13 $29.12
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 85 $28.35
J2704 Injection, propofol, 10 mg <1% 292 $9.72
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 100 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 76 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 180 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 39 $0.00
A9270 Non-covered item or service 0% 68 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 59 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 16 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 15 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 46 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialECKENFELS, DAN (PRESIDENT)